🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/01/1987 | 7,42 | 7,45 | 7,26 | 7,41 | +2,10% | 2,50% | 10.860.005 |
| 27/01/1987 | 7,21 | 7,32 | 7,16 | 7,26 | +2,15% | 2,21% | 10.537.430 |
| 26/01/1987 | 7,13 | 7,15 | 7,01 | 7,10 | -0,19% | 1,95% | 9.958.306 |
| 23/01/1987 | 7,34 | 7,66 | 7,08 | 7,12 | -1,83% | 7,94% | 19.618.560 |
| 22/01/1987 | 7,09 | 7,25 | 7,07 | 7,25 | +2,34% | 2,52% | 10.627.978 |
| 21/01/1987 | 7,02 | 7,14 | 7,02 | 7,08 | +0,47% | 1,70% | 10.145.059 |
| 20/01/1987 | 7,22 | 7,26 | 7,04 | 7,05 | -2,39% | 3,12% | 12.599.266 |
| 19/01/1987 | 7,18 | 7,23 | 7,05 | 7,22 | +0,18% | 2,49% | 8.798.170 |
| 16/01/1987 | 7,09 | 7,21 | 7,05 | 7,21 | +2,35% | 2,24% | 22.070.880 |
| 15/01/1987 | 6,81 | 7,04 | 6,77 | 7,04 | +4,11% | 4,09% | 15.079.882 |
| 14/01/1987 | 6,72 | 6,78 | 6,69 | 6,77 | +0,89% | 1,38% | 9.830.030 |
| 13/01/1987 | 6,73 | 6,76 | 6,71 | 6,71 | -0,69% | 0,79% | 7.023.067 |
| 12/01/1987 | 6,81 | 6,84 | 6,73 | 6,75 | -1,26% | 1,56% | 10.718.525 |
| 09/01/1987 | 6,85 | 6,88 | 6,83 | 6,84 | -0,48% | 0,77% | 8.528.414 |
| 08/01/1987 | 6,80 | 6,88 | 6,74 | 6,87 | +1,27% | 2,05% | 17.103.989 |
| 07/01/1987 | 6,71 | 6,79 | 6,68 | 6,79 | +0,39% | 1,58% | 13.627.354 |
| 06/01/1987 | 6,84 | 6,85 | 6,76 | 6,76 | -0,97% | 1,36% | 14.964.811 |
| 05/01/1987 | 6,84 | 6,84 | 6,76 | 6,83 | +2,18% | 1,16% | 12.091.824 |
| 02/01/1987 | 6,58 | 6,68 | 6,47 | 6,68 | +1,72% | 3,22% | 15.147.792 |
| 31/12/1986 | 6,69 | 6,71 | 6,55 | 6,57 | -1,78% | 2,38% | 8.488.800 |
| 30/12/1986 | 6,65 | 6,72 | 6,60 | 6,69 | +0,90% | 1,79% | 9.963.965 |
| 29/12/1986 | 6,73 | 6,75 | 6,60 | 6,63 | -3,47% | 2,17% | 13.746.197 |
| 26/12/1986 | 6,56 | 6,86 | 6,55 | 6,86 | +5,07% | 4,85% | 8.852.875 |
| 24/12/1986 | 6,35 | 6,57 | 6,35 | 6,53 | +2,92% | 3,44% | 9.216.950 |
| 23/12/1986 | 6,31 | 6,39 | 6,28 | 6,35 | +1,59% | 1,68% | 15.706.166 |
| 22/12/1986 | 6,18 | 6,30 | 6,16 | 6,25 | +0,86% | 2,14% | 27.352.800 |
| 19/12/1986 | 6,03 | 6,20 | 6,00 | 6,20 | +3,43% | 3,19% | 50.932.800 |
| 18/12/1986 | 6,04 | 6,04 | 5,97 | 5,99 | -0,11% | 1,10% | 7.057.022 |
| 17/12/1986 | 6,04 | 6,06 | 5,97 | 6,00 | -1,09% | 1,53% | 8.124.725 |
| 16/12/1986 | 6,02 | 6,10 | 6,00 | 6,06 | +1,22% | 1,54% | 11.791.886 |